The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




Summit Therapeutics plc - SUMM Summit Presents Data from Phase 1 Clinical Programme of Ezutromid at the EPNS Congress
12:00 22-Jun-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics to Participate in JMP Securities Life Sciences Conference
12:00 15-Jun-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : 1st Quarter Results
12:00 14-Jun-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017
12:00 05-Jun-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Announces Key Appointments to Strengthen Research & Development Team
12:00 23-May-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMD
12:00 15-May-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc: Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases
07:00 02-May-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Notice of AGM
07:00 25-Apr-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Grant of Share Options
07:00 12-Apr-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Exercise of Options
15:55 10-Apr-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics File US Annual Report on Form 20-F
07:01 31-Mar-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics to Present at the Needham Healthcare Conference
12:00 30-Mar-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics Reports 4th Quarter and Year End Financial Results and Operational Progress
12:00 29-Mar-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit to Extend Ongoing PhaseOut DMD Clinical Trial of Ezutromid in Patients with DMD
12:00 27-Mar-2017  ONE  0.00% View chart


RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



rssRNS feeds
Allows you to be kept updated with RNS announcements.


The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds